Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide Effect on Levodopa PK in Parkinson's Disease
NCT01026428Phase 2Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Sep 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Safinamide + Levodopa with Placebo + Levodopa (2 arms). Primary endpoints: Area Under the Curve of Levodopa at Day 6 and Maximum Plasma Concentration of Levodopa at Day 6. Started Sep 2009; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01026428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026428.